Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Aspen Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (209)
ARTG (9)
Australian Public Assessment Report (AusPAR) (2)
Cancellation or suspension (2)
Prescription medicine registration (2)

Date

2024 (3)
2023 (2)
2022 (9)
2020 (11)
2019 (12)
2018 (11)
2017 (92)
2016 (35)
2015 (45)
2014 (2)
2011 (1)
2007 (1)

Results for "[search-keyword]"

Search

Sponsor content

224 result(s) found, displaying 21 to 30

Aspen Pharma Pty Ltd - Ledermix paste - Dressing, dental, periodontal (305481)

28 June 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Aspen Pharma Pty Ltd - Ledermix paste - Dressing, dental, periodontal.
Aspen Pharma Pty Ltd - Ledermix cement - Zinc oxide eugenol dental cement (305482)

28 June 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Aspen Pharma Pty Ltd - Ledermix cement - Zinc oxide eugenol dental cement.
MOMASONE ALCOHOL FREE (Aspen Pharma Pty Ltd)

26 May 2020

Prescription medicine registration

Active ingredients: mometasone furoate.
SURLAX ORAL LIQUID lactulose 667 mg/mL bottle Section 30(1)(c) of the Act

28 April 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
LAILA-35 ED cyproterone acetate 2 mg and ethinylestradiol 35 micrograms tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 February 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
CYPROCUR 100 cyproterone acetate 100mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 February 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
CYPROCUR 50 cyproterone acetate 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 February 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
CHELSEA-35 ED cyproterone acetate 2 mg and ethinylestradiol 35 micrograms tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 February 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
ASPECILLIN VK phenoxymethylpenicillin 250mg (as potassium) capsule bottle Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
ASPECILLIN V Phenoxymethylpenicillin (as Benzathine) 250mg/5mL oral liquid suspension bottle Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.